Concordance entre prescriptions hospitalières et recommandations dans le traitement de la manie

Therapies - Tập 72 - Trang 327-337 - 2017
Edouard-Jules Laforgue1, Samuel Bulteau1, Jennyfer Cholet2,3, Caroline Victorri-Vigneau3,4, Marie Guitteny1, Nicolas Mauduit5, Jean-Marie Vanelle1,5, Anne Sauvaget1,3
1Centre d’évaluation et de traitement des troubles de l’humeur complexes, CAPPA Jacques-Prévert, Hôtel-Dieu, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
2Service universitaire d’addictologie, hôpital Saint-Jacques, CHU de Nantes, 44093 Nantes, France
3EA 4275 SPHERE « bioStatistics, Pharmacoepidemiology and Human sciEnces REsearch », faculté de médecine et pharmacie, université de Nantes, 44093 Nantes, France
4Service de pharmacologie clinique, institut de biologie, CHU de Nantes, 9, quai Moncousu, 44093 Nantes, France
5Service d’information médicale, CHU de Nantes, immeuble Deurbroucq, 44093 Nantes, France

Tài liệu tham khảo

Merikangas, 2011, Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative, Arch Gen Psychiatry, 68, 241, 10.1001/archgenpsychiatry.2011.12 American Psychiatric Association, 2013 Cholet, 2016, Troubles cognitifs chez les patients bipolaires vieillissants, Ann Med Psychol, 174, 194 Haute Autorité de santé, 2009 Base de données publique des médicaments. http://base-donnees-publique.medicaments.gouv.fr/ [Consulté le 25 juillet 2016]. Goodwin, 2009, Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology, J Psychopharmacol Oxf Engl, 23, 346, 10.1177/0269881109102919 Yatham, 2013, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013, Bipolar Disord, 15, 1, 10.1111/bdi.12025 Malhi, 2009, Clinical practice recommendations for bipolar disorder, Acta Psychiatr Scand Suppl, 439, 27, 10.1111/j.1600-0447.2009.01383.x National Institute for Health and Clinical Excellence, 2009 Grunze, 2013, The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder, World J Biol Psychiatry, 14, 154, 10.3109/15622975.2013.770551 Cipriani, 2011, Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, Lancet, 378, 1306, 10.1016/S0140-6736(11)60873-8 Yildiz, 2011, Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials, Neuropsychopharmacoly, 36, 375, 10.1038/npp.2010.192 Haro, 2011, 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery, Eur Neuropsychopharmacol, 21, 287, 10.1016/j.euroneuro.2010.08.001 Licht, 1997, Generalisability of results from randomised drug trials. A trial on antimanic treatment, Br J Psychiatry J Ment Sci, 170, 264, 10.1192/bjp.170.3.264 Wolfsperger, 2007, Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004, J Affect Disord, 99, 9, 10.1016/j.jad.2006.08.017 Geoffroy, 2012, Combination therapy for manic phases: a critical review of a common practice, CNS Neurosci Ther, 18, 957, 10.1111/cns.12017 Zarate, 2004, Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients, Am J Psychiatry, 161, 169, 10.1176/appi.ajp.161.1.169 Tohen, 2003, A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania, Arch Gen Psychiatry, 60, 1218, 10.1001/archpsyc.60.12.1218 World Health Organization, 1993 American Psychiatric Association, 2000 Nivoli, 2012, New treatment guidelines for acute bipolar mania: a critical review, J Affect Disord, 140, 125, 10.1016/j.jad.2011.10.015 Frye, 2000, A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders, J Clin Psychopharmacol, 20, 607, 10.1097/00004714-200012000-00004 Bulteau, 2016, Modalités de surveillance des sels de lithium en psychiatrie: des guidelines à la pratique, Ann Med Psychol, 174, 64 Bellivier, 2014, Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd), Encephale, 40, 392, 10.1016/j.encep.2014.08.002 Goikolea, 2013, Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania, Eur Neuropsychopharmacol, 23, 305, 10.1016/j.euroneuro.2012.05.017 Rosa, 2010, Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study, J Clin Psychiatry, 71, 1000, 10.4088/JCP.09m05026gre Dunayevich, 2000, Prevalence and description of psychotic features in bipolar mania, Curr Psychiatry Rep, 2, 286, 10.1007/s11920-000-0069-4 Keck, 1995, Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders, J Clin Psychiatry, 56, 466 Bourin, 2014, Can antipsychotic agents be considered as real antimanic treatments?, Front Psychiatry, 10.3389/fpsyt.2014.00060 Andréoli, 2013, Prescriptions hors autorisation de mise sur le marché en psychiatrie publique hospitalière, Therapie, 68, 347, 10.2515/therapie/2013054 Zyto, 2016, A pilot study of a combined group and individual functional remediation program for patients with bipolar I disorder, J Affect Disord, 194, 9, 10.1016/j.jad.2016.01.029